CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

listed Abbisko Medicine climbs after chairman boosts stake

By Reuters News23 hours ago Updated

** Shares of Abbisko Medicine 2256.HK climb 4.4% to HK$6.945, their highest level since November 5 and on course for a third consecutive session of gains

** The oncology-focused innovative medicines developer says founder and Chairman Xu Yao-Chang purchased 145,000 shares, or 0.02% of the issue share capital, at an average price of HK$6.67 each in the open market on November 11, raising his stake to 11.26%

** Company says Xu is confident about the business prospect and growth of the group and he may further increase his shareholding in the company when appropriate

** YTD, stock down 46.9%, Hang Seng Biotech Index .HSBIO up 7.3%

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.